Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hodgkin Disease × camrelizumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 5 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Nasopharyngeal Carcinoma 2 Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Pancreatic Neoplasms 1 Mouth Neoplasms 1 Lung Neoplasms 1 Laryngeal Neoplasms 1 Gestational Trophoblastic Disease 1 Esophageal Squamous Cell Carcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Biliary Tract Carcinoma 1

Interventions

Cyclophosphamide 11 pembrolizumab 7 fludarabine 7 fludarabine phosphate 6 Doxorubicin 6 Vinblastine 5 Gemcitabine 5 Filgrastim 5 Dacarbazine 5 Brentuximab Vedotin 5 Bleomycin 5 Nivolumab 4 Mycophenolic Acid 4 Magnetic Resonance Spectroscopy 4 Granulocyte Colony-Stimulating Factor 4 Etoposide 4 Vincristine 3 Rituximab 3 Prednisone 3 Melphalan 3 Cisplatin 3 pegfilgrastim 2 Whole-Body Irradiation 2 Vinorelbine 2 Thiotepa 2 Tacrolimus 2 Specimen Handling 2 Radiotherapy 2 Prednisolone 2 Mesna 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡